Skip to main content

Indaptus Therapeutics, Inc.

corporate_fare Company Profile

Indaptus Therapeutics, Inc.

INDP·NASDAQ·Life Sciences·CIK 0001857044

Indaptus Therapeutics, Inc. is a clinical biotechnology company focused on developing immunotherapy products to combat cancer and viral infections. Its primary product in development is Decoy20. This candidate is designed to be used either alone or in combination with other therapies to achieve lasting responses in various conditions. These include lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infections. Decoy20 is also being developed for the treatment of advanced solid tumors. The company, which was previously known as Intec Parent, Inc., adopted the name Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is based in New York, New York.

Indaptus Therapeutics, Inc. (NASDAQ:INDP) is a publicly traded company in the Life Sciences sector. Wiseek monitors INDP SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • CEO's Stake Diluted to 8.44% Following Recent Private Placement
  • Major Shareholder Yun Yao's Stake Diluted to 31.51% Following Recent Private Placement
  • Selling Stockholders Register $72 Million in Common Stock for Resale
  • Indaptus Therapeutics Secures $12M in Deeply Discounted Offshore Private Placement at $0.60/Share
  • Indaptus Therapeutics Secures $12M in Deeply Discounted Private Placement

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$20.85M
Diluted EPS
-$21.58
Op. Cash Flow
-$14.82M
Operating Income
-$19.83M
Cash & Equivalents
$8.51M
Debt / Equity
0.00×
Shares Outstanding
2.17M sh
Source: 10-K · filed 2026-03-17 · accession 0001493152-26-010585

Dilution Risk

Low risk

Filing-implied dilution signals for INDP, detected from its recent SEC filings · latest filing 2026-06-24.

1 shelf registration

$12 Million Private Placement Completed · Significant Discount and Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with I →
$3.07 +0.04% today
52-week range · as of 2026-06-27 $0.92 – $13.44
Market cap
$343.12M
Volume
146.8K (0.1× avg)
3-mo avg 2M
Live data · 2026-07-04 10:36 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed INDP - Latest Insights

INDP
Jun 26, 2026, 8:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $3.41
Real-time Price: $3.07 info
Change: -$0.340 (-10%) info
Market Cap: $343.124M info
INDP
Jun 26, 2026, 8:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $3.41
Real-time Price: $3.07 info
Change: -$0.340 (-10%) info
Market Cap: $343.124M info
INDP
Jun 26, 2026, 5:21 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $3.41
Real-time Price: $3.07 info
Change: -$0.340 (-10%) info
Market Cap: $343.124M info
INDP
Jun 24, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.55
Real-time Price: $3.07 info
Change: -$0.480 (-14%) info
Market Cap: $343.124M info
INDP
Jun 24, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.55
Real-time Price: $3.07 info
Change: -$0.480 (-14%) info
Market Cap: $343.124M info
INDP
Jun 22, 2026, 5:25 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $3.76
Real-time Price: $3.07 info
Change: -$0.6912 (-18%) info
Market Cap: $343.124M info
INDP
Jun 05, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.31
Real-time Price: $3.07 info
Change: -$0.2401 (-7%) info
Market Cap: $343.124M info
INDP
May 15, 2026, 8:15 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.75
Real-time Price: $3.07 info
Change: +$1.32 (+75%) info
Market Cap: $343.124M info
INDP
May 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.75
Real-time Price: $3.07 info
Change: +$1.32 (+75%) info
Market Cap: $343.124M info
INDP
May 15, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.75
Real-time Price: $3.07 info
Change: +$1.32 (+75%) info
Market Cap: $343.124M info
INDP
Apr 29, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $2.92
Real-time Price: $3.07 info
Change: +$0.150 (+5%) info
Market Cap: $343.124M info
INDP
Apr 22, 2026, 9:59 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.49
Real-time Price: $3.07 info
Change: -$0.420 (-12%) info
Market Cap: $343.124M info
INDP
Apr 03, 2026, 12:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.59
Real-time Price: $3.07 info
Change: +$1.48 (+93%) info
Market Cap: $343.124M info
INDP
Mar 30, 2026, 9:46 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $1.78
Real-time Price: $3.07 info
Change: +$1.29 (+72%) info
Market Cap: $343.124M info
INDP
Mar 24, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $1.68
Real-time Price: $3.07 info
Change: +$1.39 (+83%) info
Market Cap: $343.124M info
INDP
Mar 24, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $1.67
Real-time Price: $3.07 info
Change: +$1.40 (+84%) info
Market Cap: $343.124M info
INDP
Mar 24, 2026, 4:02 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.70
Real-time Price: $3.07 info
Change: +$1.37 (+81%) info
Market Cap: $343.124M info
INDP
Mar 17, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.96
Real-time Price: $3.07 info
Change: +$1.11 (+57%) info
Market Cap: $343.124M info
INDP
Mar 02, 2026, 5:20 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
10
Price at Filing: $2.10
Real-time Price: $3.07 info
Change: +$0.970 (+46%) info
Market Cap: $343.124M info
INDP
Feb 27, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.06
Real-time Price: $3.07 info
Change: +$1.01 (+49%) info
Market Cap: $343.124M info